Premier Biomedical, Inc. (BIEI)
OTCMKTS · Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
Aug 1, 2025, 2:54 PM EDT
Premier Biomedical Market Cap
Premier Biomedical has a market cap or net worth of $719.33 thousand as of August 1, 2025. Its market cap has decreased by -27.27% in one year.
Market Cap
719.33K
Enterprise Value
n/a
Revenue
14.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 8, 2012, Premier Biomedical's market cap has decreased from 13.46M to 719.33K, a decrease of -94.65%. That is a compound annual growth rate of -20.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 719.33K | 0.71% |
| Dec 31, 2024 | 714.27K | -27.78% |
| Dec 29, 2023 | 988.99K | -79.55% |
| Dec 30, 2022 | 4.84M | 44.33% |
| Dec 31, 2021 | 3.35M | 204.55% |
| Dec 31, 2020 | 1.10M | 1,302.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |